The bio-/pharmaceutical industry is one of the most research-driven in the world, and its high R&D intensity has long been recognized. This list consists of many smaller companies that have high research costs but low sales revenues. This results in enormously high intensity rates, like the one of Bellus Health with 365 thousand percent.
What is R&D intensity?
R&D intensity is calculated by taking a company’s R&D expenditure and dividing that figure by its sales. For smaller companies, the investment can be a very high proportion of its sales. However, established larger companies can recoup their R&D investment through sales income. In 2022, Swiss company Novartis spent around 10 billion U.S. dollars on R&D and had net sales of 50.5 billion U.S. dollars. This resulted in an R&D intensity for the year of around 20 percent.
R&D holds the key
Discovering innovative, life-changing medicines can require substantial investment. In 2022, the global pharmaceutical industry spent approximately 244 billion U.S. dollars on R&D, and forecasts predict an annual expenditure of over 300 billion U.S. dollars by 2028. All of the big pharma companies are expected to continue investing significant amounts on R&D projects in the future.
World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
European Commission, & Joint Research Centre. (December 14, 2023). World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022 [Graph]. In Statista. Retrieved October 31, 2024, from https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission, und Joint Research Centre. "World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022." Chart. December 14, 2023. Statista. Accessed October 31, 2024. https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission, Joint Research Centre. (2023). World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022. Statista. Statista Inc.. Accessed: October 31, 2024. https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission, and Joint Research Centre. "World's Top 50 Pharmaceutical and Biotechnology Companies Based on R&d Intensity in 2022." Statista, Statista Inc., 14 Dec 2023, https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission & Joint Research Centre, World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022 Statista, https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/ (last visited October 31, 2024)
World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022 [Graph], European Commission, & Joint Research Centre, December 14, 2023. [Online]. Available: https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/